Discovery CRO
Enhance the computational component of your research project with Cresset Discovery CRO
Dr Ashraf Zarkan and Dr David Summers, Department of Genetics, University of Cambridge
Learn more in this case study
Watch our webinar: Discovering a novel therapy for urinary tract infections through outsourcing in-silico drug discovery
Professor Nikola Bowden, University of Newcastle
From analysis of the druggable target (A) to creation of the ligand-based template for virtual screening (B) to analysis of the electrostatic potential of the ligand protein interactions (C)
Learn more in this case study
Watch our webinar: Australian program for drug repurposing for treatment resistant ovarian cancer
Emeritus Professor Richard Head, Drug Discovery and Development, Clinical and Health Sciences, University of South Australia
a) CDKi73 X-ray PDB: 4BCI b) refinement using EC scoring from FlareTM c) field point representation as the 'template' for Blaze virtual screening
S. Islam et al., Combined In Silico and In Vitro Evidence Supporting an Aurora A Kinase Inhibitory Role of the Anti-Viral Drug Rilpivirine and an Anti-Proliferative Influence on Cancer Cells, Pharmaceuticals 2022
Learn more in this poster
Watch our webinar: The power of combining computational chemistry with experimental drug repurposing
Find out how Cresset Discovery can collaborate with you to apply intelligent computational solutions and expertise that will drive your project forward. From help with writing your grant application, through to a range of protein-centric and ligand-centric solutions, our experienced scientists can help accelerate your research at every stage.
We help you reach your next milestone faster and more cost effectively
Contact us for a free confidential discussion